News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Veneman Ann M
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/08/2023 |
4
| Veneman Ann M (Director) has filed a Form 4 on Icosavax, Inc.|
Txns:
| Granted 17,000 options to buy
@ $9.89, valued at
$168.1k
|
|
| 06/14/2022 |
4
| Veneman Ann M (Director) has filed a Form 4 on Icosavax, Inc.|
Txns:
| Granted 5,543 shares
@ $0
Granted 22,278 options to buy
@ $6.25, valued at
$139.2k
|
|
| 08/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/02/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/12/2017 |
4
| Veneman Ann M (Director) has filed a Form 4 on ALEXION PHARMACEUTICALS INC|
Txns:
| Granted 2,030 shares
@ $0 |
|
| 05/13/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/09/2013 |
4
| Veneman Ann M (Director) has filed a Form 4 on ALEXION PHARMACEUTICALS INC|
Txns:
| Granted 3,425 options to buy
@ $96.35, valued at
$330k
|
|
| 05/01/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/08/2013 |
4
| Veneman Ann M (Director) has filed a Form 4 on ALEXION PHARMACEUTICALS INC|
Txns:
| Granted 2,471 shares
@ $0 |
|
| 12/14/2012 |
4
| Veneman Ann M (Director) has filed a Form 4 on ALEXION PHARMACEUTICALS INC|
Txns:
| Sold 4,579 shares
@ $95, valued at
$435k
|
|
| 02/21/2012 |
4
| Veneman Ann M (Director) has filed a Form 4 on ALEXION PHARMACEUTICALS INC|
Txns:
| Sold 2,000 shares
@ $81.1, valued at
$162.2k
|
|
| 05/13/2011 |
4
| Veneman Ann M (Director) has filed a Form 4 on ALEXION PHARMACEUTICALS INC|
Txns:
| Granted 2,786 options to buy
@ $98.86, valued at
$275.4k
|
|
| 02/04/2011 |
4
| Veneman Ann M (Director) has filed a Form 4 on ALEXION PHARMACEUTICALS INC|
Txns:
| Exercised 2,725 shares
@ $0 |
|
| 06/01/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|